2772-3747

JACC Asia

Elsevier

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1091 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1091 DOIs
2

Attach ORCID iDs across 491 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact491 DOIs
3

Deposit reference lists for 109 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact109 DOIs

DOIs for this ISSN

Showing the top 5 of 1091 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Epidemiological Features of Cardiovascular Disease in Asia (10.1016/j.jacasi.2021.04.007)
Abstract ORCID
122.05 275
2 Distribution, Characteristics, and Management of Older Patie… (10.1016/j.jacasi.2021.11.013)
Abstract ORCID
90.65 64
3 Lipoprotein(a) and Cardiovascular Disease in Chinese Populat… (10.1016/j.jacasi.2022.08.015)
Abstract ORCID
89.27 60
4 20-Year Trends in Metabolic Syndrome Among Korean Adults Fro… (10.1016/j.jacasi.2023.02.007)
Abstract ORCID
85.80 51
5 Antithrombotic Therapy After Acute Coronary Syndromes or Per… (10.1016/j.jacasi.2021.12.005)
Abstract ORCID
83.60 46
6 Pulmonary Hypertension Caused by Fibrosing Mediastinitis (10.1016/j.jacasi.2021.11.016)
Abstract ORCID
82.66 44
7 Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarco… (10.1016/j.jacasi.2021.09.005)
Abstract ORCID
82.17 43
8 Ischemia With Nonobstructive Coronary Artery Disease (10.1016/j.jacasi.2023.01.004)
Abstract ORCID
80.64 40
9 Percutaneous Coronary Intervention for Left Main Coronary Ar… (10.1016/j.jacasi.2021.12.011)
Abstract ORCID
80.10 39
10 Transcatheter Aortic Valve Replacement in Asia (10.1016/j.jacasi.2021.10.006)
Abstract ORCID
75.93 32
11 Advances in Diagnosis, Therapy, and Prognosis of Coronary Ar… (10.1016/j.jacasi.2022.12.005)
Abstract ORCID
73.86 29
12 Cardiac Optical Coherence Tomography (10.1016/j.jacasi.2023.10.001)
Abstract ORCID
73.86 29
13 Residual Inflammatory Risk and its Association With Events i… (10.1016/j.jacasi.2021.11.014)
Abstract ORCID
73.12 28
14 Bidirectional Associations Between Cardiometabolic Multimorb… (10.1016/j.jacasi.2024.06.004)
Abstract ORCID
73.12 28
15 Tafolecimab in Chinese Patients With Hypercholesterolemia (C… (10.1016/j.jacasi.2023.04.011)
Abstract ORCID
72.36 27
16 Photoplethysmography-Based Machine Learning Approaches for A… (10.1016/j.jacasi.2021.09.004)
Abstract ORCID
71.57 26
17 Sex Differences in the Association Between Depression and In… (10.1016/j.jacasi.2023.11.015)
Abstract ORCID
71.57 26
18 Tip Detection–Antegrade Dissection and Re-Entry With New Pun… (10.1016/j.jacasi.2023.11.017)
Abstract ORCID
71.57 26
19 Brugada Syndrome as a Major Cause of Sudden Cardiac Death in… (10.1016/j.jacasi.2022.03.011)
Abstract ORCID
69.90 24
20 Efficacy and Safety of Inclisiran in Asian Patients (10.1016/j.jacasi.2023.09.006)
Abstract ORCID
69.90 24
21 Machine Learning Risk Prediction for Incident Heart Failure… (10.1016/j.jacasi.2022.07.007)
Abstract ORCID
69.01 23
22 Atrial Fibrillation Better Care Pathway Adherent Care Improv… (10.1016/j.jacasi.2022.01.007)
Abstract ORCID
66.11 20
23 Evaluation of Atherosclerotic Cardiovascular Risk Prediction… (10.1016/j.jacasi.2021.10.007)
Abstract ORCID
65.05 19
24 Effect of the ALDH2 Variant on the Prevalence of Atrial Fibr… (10.1016/j.jacasi.2021.10.009)
Abstract ORCID
65.05 19
25 Physiology-Based Revascularization (10.1016/j.jacasi.2021.03.002)
Abstract ORCID
63.94 18
26 The Use of Machine Learning for the Care of Hypertension and… (10.1016/j.jacasi.2021.07.005)
Abstract ORCID
63.94 18
27 A Novel Model of Integrated Care of Older Patients With Atri… (10.1016/j.jacasi.2024.07.006)
Abstract ORCID
63.94 18
28 Status of Cardiovascular Health in Chinese Children and Adol… (10.1016/j.jacasi.2021.09.007)
Abstract ORCID
62.76 17
29 Different Renal Function Equations and Dosing of Direct Oral… (10.1016/j.jacasi.2021.11.006)
Abstract ORCID
62.76 17
30 Clinical Characteristics of Homozygous Familial Hypercholest… (10.1016/j.jacasi.2023.07.011)
Abstract ORCID
62.76 17
31 Validation of the Khorana Venous Thromboembolism Risk Score… (10.1016/j.jacasi.2021.07.006)
Abstract ORCID
61.52 16
32 First-in-Human Study of the Novel Transcatheter Mitral Valve… (10.1016/j.jacasi.2022.03.010)
Abstract ORCID
61.52 16
33 Diabetes-Related Cardiovascular and All-Cause Mortality in A… (10.1016/j.jacasi.2022.12.010)
Abstract ORCID
61.52 16
34 5-Year Outcome of Simple Crossover Stenting in Coronary Bifu… (10.1016/j.jacasi.2021.04.002)
Abstract ORCID
58.80 14
35 Impact of Age and Sex on Subclinical Coronary Atherosclerosi… (10.1016/j.jacasi.2021.05.002)
Abstract ORCID
58.80 14
36 Lowering the Recommended Maximal Wall Thickness Threshold Im… (10.1016/j.jacasi.2021.07.001)
Abstract ORCID
58.80 14
37 Incidence, Prediction, and Outcomes of Major Bleeding After… (10.1016/j.jacasi.2021.12.009)
Abstract ORCID
58.80 14
38 Renal Function and Clinical Outcomes Among Elderly Patients… (10.1016/j.jacasi.2023.02.002)
Abstract ORCID
58.80 14
39 Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker (10.1016/j.jacasi.2023.02.006)
Abstract ORCID
58.80 14
40 RNF213 p.R4810K Variant Increases the Risk of Vasospastic An… (10.1016/j.jacasi.2023.05.002)
Abstract ORCID
58.80 14
41 Dementia Risk of Direct Oral Anticoagulants Versus Warfarin… (10.1016/j.jacasi.2023.07.012)
Abstract ORCID
58.80 14
42 Association of Vascular Aging With Cardiovascular Disease in… (10.1016/j.jacasi.2023.07.014)
Abstract ORCID
58.80 14
43 Prognostic Implications of Comprehensive Whole Vessel Plaque… (10.1016/j.jacasi.2021.05.003)
Abstract ORCID
57.31 13
44 Long-Term Outcomes of Surgical Ablation for Atrial Fibrillat… (10.1016/j.jacasi.2021.06.001)
Abstract ORCID
57.31 13
45 Substantially Elevated Atherosclerotic Risks in Japanese Sev… (10.1016/j.jacasi.2021.07.004)
Abstract ORCID
57.31 13
46 Application of Balloon-Expandable Transcatheter Heart Valve… (10.1016/j.jacasi.2021.07.012)
Abstract ORCID
57.31 13
47 Impact of Frailty on Postoperative Dysphagia in Patients Und… (10.1016/j.jacasi.2021.10.011)
Abstract ORCID
57.31 13
48 Shortening Dual Antiplatelet Therapy Duration in High-Risk P… (10.1016/j.jacasi.2022.10.008)
Abstract ORCID
57.31 13
49 A Potential Long-Acting LDL-Cholesterol–Lowering PCSK9 Monoc… (10.1016/j.jacasi.2021.09.002)
Abstract ORCID
55.70 12
50 A Comprehensive Insight and Mechanistic Understanding of the… (10.1016/j.jacasi.2023.06.001)
Abstract ORCID
55.70 12